Help for Fluffy: Pet drug developer Kindred files for $57.5 million IPO

The biotech IPO market is going to the dogs … and cats and horses. Kindred Biosciences Inc., a Burlingame company that hopes to turn approved drugs for humans into therapies for animals, filed Friday for a $57...